One study showed an association between increased bFGF expression in tumors and shorter survival in node-negative breast cancer patients [12], whereas other studies showed an association between increased intra-tumoral bFGF expression and better prognosis in breast cancer patients [13-17]. Here, FGF2 is linked to breast cancer.